Online Submissions

Already have a Username/Password for International Journal of Cancer Therapy and Oncology?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines

International Journal of Cancer Therapy and Oncology (IJCTO) follows specific guidelines regarding the format of the manuscript being published to maintain uniformity of all the articles for the ease to the readers. Before submitting the articles, please follow the instructions and the check lists provided on the manuscript submission page.

Editorial Process

After the manuscript submission by the author/s, the Editor will review the manuscripts with the understanding that they are being submitted to one journal at a time and have not been published, simultaneously submitted or already accepted for publication elsewhere. If the Editor determines the manuscript is appropriate for the IJCTO, it will be sent to two reviewers without revealing the identification of the authors. The Editors reserve the right to choose the reviewers. Based on the comments from the reviewers, the Editor will make a final decision on the manuscript. The authors will be informed about reviewers comments, suggestions, and acceptance/rejection within a period of 3-5 weeks. Once the manuscript has been accepted, it would be copy edited for grammar, punctuation, print style, and format. The corresponding author will receive a copy edited article for any correction, which needs to be returned within one week.

Authors may recommend 2-4 potential reviewers, who are expert in the field of author's work. The recommendations can be made in the cover letter during the Online Submission of the article. The editor has full right on the selection of the reviewers. 

Articles Category

  1. Original Research Articles: These should include original experimental or theoretical investigation that represent new and significant contributions to the field of cancer therapy and oncology. Limit: 15 pages.
  2. Review Articles: These should include reviews of major areas or sub-areas in the field of cancer therapy and oncology. Limit: 20 pages.
  3. Technical Notes: These should include a brief description of a new procedure or technique, which has sufficient relevance to be useful to readers and other researchers. Limit: 5 pages.
  4. Case Studies: These should include a concise description of a technique, procedure, clinical implementation, or clinical patient-related complication of relevance to the practice of cancer therapy and oncology. Limit: 4 pages.
  5. Letters to the Editor/Scientific Notes: These should include the comments on papers published in IJCTO or on any other matters of interest to cancer therapy and oncology. Limit: 4 pages.
  6. Book Reviews: The editorial office solicits Book Reviews.

Manuscript Submission

You may choose one of the following methods to submit your manuscript:

1) Journal Submission System: Manuscripts are submitted online through IJCTO submission and review website ( ). IMPORTANT: New author/s will have to register as an AUTHOR for the online submission of your manuscript. For new author registration, please visit

2) Email: You can email your manuscript along with the supporting documents to

All manuscripts must be written in English. Authors whose native language is not English are encouraged to engage a native English speaker to review their manuscripts. References must be prepared according to instructions found in this page. Please note that manuscripts must be prepared in two files (Title Page and Article file). Images should be submitted separately as supplementary files.

  1. Title Page: Please download the template of the title page. CLICK HERE The title should be brief and specific. The title page should contain the title of the manuscript, Corresponding Author and Co-authors, as well as institutions and addresses for each author. If the paper was presented at a meeting, the name of the organization, place, and date of the meeting should be listed. Provide the Corresponding Author's full mailing address, telephone and fax numbers, and e-mail address.
  2. Article file: This file should not contain any information of the authors such as acknowledgements, names in page headers, etc. Please prepare the Article File in Microsoft word format in the following order:
  • Abstract : It should have the full title of the manuscript along with an Abstract no more than 300 words for the original article, review article, educational article, scientific note, technical report, and case report. Below the abstract should be provided 4 to 8 keywords.

    Abstract for original articles and Technical Reports:
    This page MUST state Background/Purpose, Methods, Results, and Conclusion. For example, see:

    Abstract for review article, educational article, scientific note, and case report: No sub-headings are required. For example, see:

  • Body of Manuscript (Introduction, Methods, Results, Discussion, and Conclusion)
  • References
  • Figures and Figure Legends (if any)
  • Tables and captions (if any)
  • Figures (separate file for each figure – figures are imbedded in the manuscript after the References)

Body of Manuscript:

Introduction: It should state the background to the research and its specific aims. Also, state what is being reported in the manuscript.

Methods: This section contains the information of techniques and procedures that was used to obtain the results. All detailed information on the research design, patients, equipment, materials, and variables should be included with the adequate reasoning of the procedures.

Results: This section must have the result in the style of: logical sequence in the text, tables, and illustrations in the order of its importance, by not repeating any information. Any additional information can be provided in an appendix.

Discussion: This section should explain the impacts of the research article’s strengths, limitations, and clear expression of the implications of study findings.

Conclusion: This section should state clearly the major findings of the research and give a clear explanation of their importance and relevance.



References should be assigned consecutive numbers as in order in the text (not in alphabetic order). Identify references in text, tables, and legends as they are mentioned, and also be listed in the same order on a separate page in the body of the text

1. Standard article:

List all authors when there are six or fewer, otherwise, list only the first three, followed by et al.

Jia Y, Beltran C, Indelicato DJ, Flampouri S, Li Z, Merchant TE. Proton therapy dose distribution comparison between Monte Carlo and a treatment planning system for pediatric patients with ependymoma. Med Phys. 2012;39(8):4742-7. doi: 10.1118/1.4736413.

2. Book:

List all authors or editors when there are six or fewer, otherwise, list only the first three, followed by et al.

Bentel GC, Nelson CE, Noel KT. Treatment planning and dose calculation in radiation oncology. 3rd ed. Elmsford, NY: Pergamon Press; 1986.

3. Online References

Weyh A, Konski A, Nalichowski A, Maier J, Lack D. Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMR.  [Electronic version]. J Appl Clin Med Phys. 2013;14(4):4065. Retrieved July 20, 2013, from



Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. My manuscript is prepared in word (.doc) format.

    If you have prepared your manuscript in .docx type, please save it as .doc format.

    We are facing some technical issue with uploading .docx files, and we are working on resolving it.

    If you continue to face technical issue while uploading the manuscript, please email your manuscript to

  2. Do not provide any sort of author and institutional information in the paper. This is a double-blind peer-review process. If the paper is accepted, we will ask for the title page and other relevant information
  3. References should be assigned consecutive numbers as in order in the text (not in alphabetic order). Identify references in text, tables, and legends as they are mentioned, and also be listed in the same order on a separate page in the body of the text.

    Also, please make sure to have references are provided in PubMed or Vancouver format.

  4. I understand that the IJCTO is committed to publishing only original material, i.e., material that has neither been published elsewhere, nor is under review elsewhere. Manuscripts that are found to have been plagiarized from other manuscripts, whether published or unpublished, will incur plagiarism sanctions.

Copyright Notice

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.



International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.


Number of visits since October, 2013